Suppose we consider the serum vitamin-E assay a screening test for compliance with vitamin-E supplementation. This study aims to identify a threshold Δ, such that participants whose change in serum vitamin E is ≥ Δ mg/dL will be considered vitamin-E takers, and participants whose change is < Δ mg/dL will be considered placebo takers.

Suppose a change of 0.30 mg/dL in serum levels is proposed as a test criterion for compliance. What percentage of the vitamin-E group would be expected to show a change of at least 0.30 mg/dL? (3 points)

What percentage of the placebo group would be expected to show a change of not more than 0.30 mg/dL? (3 points)


To approach this problem, we need to apply the concepts of hypothesis testing, where the serum vitamin E change of 0.30 mg/dL serves as a threshold (\(\Delta = 0.30\) mg/dL) for determining compliance. In this context, we need to use the given change in serum vitamin E as a cutoff point for two groups: the vitamin-E group (treatment) and the placebo group.

Let’s break the problem into two parts and approach each separately:

### Part 1: Percentage of Vitamin-E Group Showing a Change of at Least 0.30 mg/dL

This part of the problem is asking for the percentage of participants in the vitamin-E group whose change in serum vitamin E is **greater than or equal to 0.30 mg/dL**. To calculate this, we would typically need to know the distribution of serum vitamin E changes in the vitamin-E group, which is likely to follow a normal distribution. The key information we would need includes:

- The **mean** and **standard deviation** of serum vitamin E changes in the vitamin-E group.

With this information, we could calculate the probability that a randomly chosen participant from the vitamin-E group has a change in serum vitamin E that is greater than or equal to 0.30 mg/dL. This probability can be found using a standard normal distribution (z-table) after standardizing the value of 0.30 mg/dL.

Let’s assume the serum vitamin E change for the vitamin-E group is normally distributed with a mean \(\mu_1\) and standard deviation \(\sigma_1\). Then we standardize the change of 0.30 mg/dL to find the z-score:

\[
z = \frac{0.30 - \mu_1}{\sigma_1}
\]

Once the z-score is calculated, the percentage of participants whose serum vitamin E change is at least 0.30 mg/dL can be found by looking up the corresponding value in a z-table.

### Part 2: Percentage of Placebo Group Showing a Change of Not More Than 0.30 mg/dL

This part of the problem is asking for the percentage of participants in the placebo group whose change in serum vitamin E is **less than or equal to 0.30 mg/dL**. Similar to the first part, we would typically assume that the change in serum vitamin E in the placebo group follows a normal distribution.

Let’s assume the serum vitamin E change for the placebo group is normally distributed with a mean \(\mu_2\) and standard deviation \(\sigma_2\). We would calculate the z-score for 0.30 mg/dL in the placebo group:

\[
z = \frac{0.30 - \mu_2}{\sigma_2}
\]

Once we have this z-score, we can use a z-table to find the percentage of participants in the placebo group whose serum vitamin E change is **not more than 0.30 mg/dL**.

### Conclusion

To finalize the percentages for both groups, we need the means (\(\mu_1\) for the vitamin-E group and \(\mu_2\) for the placebo group) and standard deviations (\(\sigma_1\) and \(\sigma_2\)) of their respective distributions. The solution is then a straightforward application of the z-score formula and the standard normal distribution.

---

Let me know if you want details on finding the z-scores or how to use the z-table! 

Here are some related questions:

1. What is the z-score formula and how is it used to standardize values?
2. How do you interpret probabilities from a z-table?
3. How does changing the mean or standard deviation affect the z-score?
4. What is the meaning of a z-score in terms of standard deviations from the mean?
5. How can the normal distribution be used in real-world medical testing?

**Tip:** Understanding the normal distribution is critical for interpreting many medical tests, as it helps us measure how likely outcomes are relative to an average.

Suppose we consider the serum vitamin-E assay a screening test for compliance with vitamin-E supplementation. This study aims to identify a threshold Δ, such that participants whose change in serum vitamin E is ≥ Δ mg/dL will be considered vitamin-E takers, and participants whose change is < Δ mg/dL will be considered placebo takers.

Suppose a change of 0.30 mg/dL in serum levels is proposed as a test criterion for compliance. What percentage of the vitamin-E group would be expected to show a change of at least 0.30 mg/dL? (3 points)

What percentage of the placebo group would be expected to show a change of not more than 0.30 mg/dL? (3 points)

Learn how to determine compliance with vitamin-E supplementation by using a serum vitamin-E assay as a screening test. This problem involves calculating the percentage of the vitamin-E group and placebo group showing specific changes in serum levels using the normal distribution and Z-scores. Suitable for university-level statistics students.

Math Problem Statement

Solution

Ask a new question for Free

By Image

Math Problem Analysis

Mathematical Concepts

Formulas

Theorems

Suitable Grade Level

Related Recommendation